Orthofix Medical Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M | $406.6M | $460.0M | $453.0M |
| Cost of Revenue | $256.3M | $253.6M | $260.4M | $123.5M | $114.9M | $101.9M | $100.6M | $96.6M |
| Gross Profit | $566.0M | $545.9M | $486.3M | $337.2M | $349.6M | $304.7M | $359.3M | $356.4M |
| Gross Margin | 68.8% | 68.3% | 65.1% | 73.2% | 75.3% | 74.9% | 78.1% | 78.7% |
| Operating Expenses | ||||||||
| Research & Development | $65.8M | $73.6M | $80.2M | $49.1M | $49.6M | $39.1M | $34.6M | $33.2M |
| SG&A Expense | $554.3M | $532.5M | $530.4M | $308.8M | $69.4M | $67.9M | $85.6M | $83.3M |
| Operating Income | $-81.4M | $-84.6M | $-139.1M | $-13.3M | $-8.3M | $-6.3M | $-18.8M | $30.1M |
| Operating Margin | -9.9% | -10.6% | -18.6% | -2.9% | -1.8% | -1.5% | -4.1% | 6.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-90.8M | $-123.9M | $-148.7M | $-17.7M | $-13.5M | $-368.0K | $-27.0M | $22.9M |
| Income Tax Expense | $1.4M | $2.1M | $2.7M | $2.0M | $24.9M | $-2.9M | $1.4M | $9.1M |
| Net Income | $-92.2M | $-126.0M | $-151.4M | $-19.7M | $-38.4M | $2.5M | $-28.5M | $13.8M |
| Net Margin | -11.2% | -15.8% | -20.3% | -4.3% | -8.3% | 0.6% | -6.2% | 3.0% |
| EPS (Basic) | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 | $0.13 | $-1.51 | $0.73 |
| EPS (Diluted) | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 | $0.13 | $-1.51 | $0.72 |
| Shares Outstanding (Basic) | 39.6M | 38.1M | 36.7M | 20.1M | 19.7M | 19.3M | 18.9M | 18.5M |
| Shares Outstanding (Diluted) | 39.6M | 38.1M | 36.7M | 20.1M | 19.7M | 19.4M | 18.9M | 18.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |